Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

1.5K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Structure and Function of Platelets01:18

Structure and Function of Platelets

2.3K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

789
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
789
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

7.9K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.9K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

7.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigator-Led Research to Improve the Diagnostic Assessment of Platelet Function Disorders: Reflections on the Challenges and Rewards.

International journal of laboratory hematology·2026
Same author

A different alternative to warfarin?

Blood advances·2026
Same author

The first clotting factor is also the last.

Blood·2026
Same author

A Retrospective Study of Adult and Pediatric D-Dimer Tests to Identify Opportunities for Improved Utilization.

International journal of laboratory hematology·2025
Same author

Platelet Polyphosphate Signals Through NFκB to Induce Myofibroblast Differentiation.

Biomolecules·2025
Same author

Crystal structure of coagulation factor XII N-terminal domains 1-5.

Acta crystallographica. Section D, Structural biology·2025
Same journal

Pilot-Scale Evaluation of Partial-Slide Imaging for Detecting Critical Morphological Features (Excluding Parasites): Initial UK Implementation of a Hybrid Virtual-Light Microscopy Model in Haematology.

International journal of laboratory hematology·2026
Same journal

Testing for Non-Severe Heritable Platelet Function Disorders.

International journal of laboratory hematology·2026
Same journal

Thrombocytopenia in Pregnancy: A 5-Year Analysis of Characteristics and Practices From a Tertiary Academic Center.

International journal of laboratory hematology·2026
Same journal

AI In Leukemia Diagnostics: Complementing the Pathologist's Role.

International journal of laboratory hematology·2026
Same journal

Advanced Molecular Analysis in Hemophilia A in a Single Step: Next Generation Sequencing (NGS) and Copy Number Variation (CNV) Analysis.

International journal of laboratory hematology·2026
Same journal

Overwhelming Post-Splenectomy Sepsis From Capnocytophaga canimorsus.

International journal of laboratory hematology·2026
See all related articles

Related Experiment Video

Updated: Oct 31, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

794

Thrombin generation abnormalities in commonly encountered platelet function disorders.

Tanmya Sharma1, Justin G Brunet1, Subia Tasneem1

  • 1Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.

International Journal of Laboratory Hematology
|June 29, 2021
PubMed
Summary
This summary is machine-generated.

Thrombin generation (TG) is impaired in platelet function disorders (PFD), affecting both platelet-rich plasma (PRP) and platelet-poor plasma (PPP) samples. These TG impairments correlate with bleeding symptoms, highlighting their clinical relevance.

Keywords:
bleedingblood platelet disorderscoagulationplatelet storage pool deficiencythrombin generation

More Related Videos

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.2K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.0K

Related Experiment Videos

Last Updated: Oct 31, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

794
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.2K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.0K

Area of Science:

  • Hemostasis and Thrombosis Research
  • Platelet Physiology
  • Bleeding Disorder Diagnostics

Background:

  • Thrombin generation (TG) studies using platelet-rich plasma (PRP) and platelet-poor plasma (PPP) are crucial for understanding bleeding disorders.
  • Platelet function disorders (PFD) represent a common group of hemostatic abnormalities.
  • This study investigates TG in a cohort with frequently observed PFDs.

Purpose of the Study:

  • To evaluate thrombin generation (TG) in patients with common platelet function disorders (PFD).
  • To explore the relationship between TG in platelet-rich plasma (PRP) and platelet-poor plasma (PPP) in PFD.
  • To identify potential correlations between TG parameters, platelet characteristics, and bleeding symptoms in PFD.

Main Methods:

  • Recruitment of 40 controls and 31 patients with PFD (dense granule deficiency, RUNX1 haploinsufficiency, or uncharacterized aggregation defects).
  • Assessment of TG using both PRP and PPP samples.
  • Analysis of platelet-derived factors including ADP, polyphosphate, tissue factor pathway inhibitor (TFPI), factor V (FV), and ANO6 transcript levels.

Main Results:

  • Patients with PFD exhibited impaired TG in both PRP and PPP, with strong correlations between these measures.
  • PFD-DGD (dense granule deficiency) PRP TG showed partial improvement with polyphosphate and agonist addition.
  • PFD patients displayed elevated plasma TFPI and reduced platelet TFPI, with plasma TFPI levels associated with PPP TG endpoints.

Conclusions:

  • Thrombin generation is demonstrably impaired across various common platelet function disorders.
  • Findings in PRP TG show significant associations with clinical bleeding symptoms in PFD patients.
  • These results underscore the utility of TG assays in assessing PFD and their clinical manifestations.